EastWest Bioscience (EastWest Bioscience) FCF Margin % : -4.76% (As of Apr. 2022)

View and export this data going back to 2018. Start your Free Trial

What is EastWest Bioscience FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. EastWest Bioscience's Free Cash Flow for the three months ended in Apr. 2022 was $-0.00 Mil. EastWest Bioscience's Revenue for the three months ended in Apr. 2022 was $0.06 Mil. Therefore, EastWest Bioscience's FCF Margin % for the quarter that ended in Apr. 2022 was -4.76%.

As of today, EastWest Bioscience's current FCF Yield % is 0.00%.

The historical rank and industry rank for EastWest Bioscience's FCF Margin % or its related term are showing as below:

HBOSF' s FCF Margin % Range Over the Past 10 Years
Min: -163.36 Med: 0 Max: 0
Current: -163.36

HBOSF's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.265 vs HBOSF: -163.36

EastWest Bioscience FCF Margin % Historical Data

The historical data trend for EastWest Bioscience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EastWest Bioscience FCF Margin % Chart

EastWest Bioscience Annual Data

Trend

Oct15

Oct16

Oct17

Jul18

Jul19

Jul20

Jul21

FCF Margin %

Get a 7-Day Free Trial

-2,445.92

-167.30

-35.23

-111.20

EastWest Bioscience Quarterly Data
	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22
FCF Margin %	Get a 7-Day Free Trial															29.52	-4,128.57	-72.22	-38.89	-4.76

Competitive Comparison of EastWest Bioscience's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, EastWest Bioscience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EastWest Bioscience's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EastWest Bioscience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where EastWest Bioscience's FCF Margin % falls into.

EastWest Bioscience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

EastWest Bioscience's FCF Margin for the fiscal year that ended in Jul. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2021 )	/	Revenue (A: Jul. 2021 )
	=	-0.556	/	0.5
	=	-111.20 %

EastWest Bioscience's FCF Margin for the quarter that ended in Apr. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Apr. 2022 )	/	Revenue (Q: Apr. 2022 )
	=	-0.003	/	0.063
	=	-4.76 %

EastWest Bioscience FCF Margin % Related Terms

Thank you for viewing the detailed overview of EastWest Bioscience's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

EastWest Bioscience (EastWest Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EastWest Bioscience Inc (GREY:HBOSF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

260 Okanagan Avenue East, Penticton, BC, CAN, V2A 3J7

Website

https://www.eastwestbioscience.com

EastWest Bioscience Inc is a seed-to-sale organization. The company is a producer, manufacturer, and distributor of multiple lines of premium hemp products. The business operating segment includes corporate, retailing, franchise and distribution, and property management and manufacturing. The Company's business activity is developing premium quality hemp nutritional products for people and pets.